microRNA-181a inhibits ocular neovascularization by interfering with vascular endothelial growth factor expression.

Chun YangHouda TahiriChenrongrong CaiMuqing GuCarmen GagnonPierre Hardy

Published in: Cardiovascular therapeutics (2018)

These data may open unexpected avenues for the development of miR-181a as a novel therapeutic strategy that would be particularly useful and relevant for the treatment of neovascular diseases.

Keyphrases

vascular endothelial growth factor
endothelial cells
poor prognosis
long non coding rna
cell proliferation
long noncoding rna
electronic health record
big data
combination therapy
deep learning
artificial intelligence